The report presents the market potential of seven major pipeline drugs meant for the treatment of migraine. These seven drugs that fall in the various categories of Ergotamines, Anti 5-HT Receptor Agonists and Anti-CGRPs by mechanism of action have been recognized as being clinically effective in migraine treatment. Expected to be launched in the market within the next 4-5 years, these seven potential drugs are likely to bring about major changes in the way migraine is treated globally.
Global Psoriasis Pipeline Drugs Market Assessment – Forecast to 2023AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Psoriasis Pipeline Drugs Market by assessing the potential of the six drugs that will be launched in the near future. Also, the report assesses the results of various clinical trials undertaken for each of the six drugs, the product profile, description and regulatory phase of each of the six drugs. Also, 7Ps Analysis (Patent, Phase, Pathway, Patient, Physician, Payer, Partner) has been done for each of the six drugs to present the current perspective.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of COPD Drugs Market. The report analyses the COPD Drugs Market By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, andOthers). The report analyses the COPD Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023. This report also includes pipeline analysis for few COPD drugs. Request free Sample of this Report @ http://azothanalytics.com/report/healthcare-pharma/global-copd-drugs-market-analysis-by-drug-type-combination-therapy-anticholinergics-beta-agonist-inhaled-corticosteroids-others-pipeline-drugs-by-region-by-country-2019-edition-forecast-to-2023-r29194 COPD Drugs Market Analysis
Visit us: http://azothanalytics.com/research/healthcare-pharma-c1
Global Hepatitis B Virus [HBV] Treatment Market: Opportunities and Forecast (...Matloob Hasan
The global Hepatitis B treatment market growth is backed by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Moreover, the global market growth is driven by the rising global healthcare expenditure, healthcare infrastructure development and changing lifestyle is expected to supplement the market growth during the forecast period.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others). The report analyses the Antifungal Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023.Visit us: http://azothanalytics.com/report/healthcare-pharma/global-antifungal-drugs-market-analysis-by-drug-class-azoles-echinocandins-polyenes-others-by-therapeutic-indications-candidiasis-aspergillosis-dermatophytosis-others-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28194
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Capsule Endoscopy Market Is Anticipated To Touch 886.3 Million In 2022: Grand...Amit M
The Global Capsule Endoscopy Market is expected to reach USD 886.3 million by 2022; according to a new study by Grand View Research, Inc. Increasing prevalence of colorectal cancer, GI diseases and growing demand for precise and accurate diagnostic tools are expected to drive the capsule endoscopy market.
Global Inflammatory Bowel Diseases (IBD) Drug Market Forecast 2017-2027Visiongain
For a report overview of this report please contact sara.peerun@visiongainglobal.com
(+44 (0) 20 7336 6100) or refer to our website:
https://www.visiongain.com/
https://www.visiongain.com/Report/1830/Global-Inflammatory-Bowel-Diseases-(IBD)-Drug-Market-Forecast-2017-2027
"The Global In Vitro Diagnostics (IVD) Market is calculated to reach $91.49 billion by 2024, at a CAGR of
6.01% during the forecast period 2019-2024. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories,
increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the
key factors driving the growth of the market."
Global Psoriasis Pipeline Drugs Market Assessment – Forecast to 2023AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Psoriasis Pipeline Drugs Market by assessing the potential of the six drugs that will be launched in the near future. Also, the report assesses the results of various clinical trials undertaken for each of the six drugs, the product profile, description and regulatory phase of each of the six drugs. Also, 7Ps Analysis (Patent, Phase, Pathway, Patient, Physician, Payer, Partner) has been done for each of the six drugs to present the current perspective.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of COPD Drugs Market. The report analyses the COPD Drugs Market By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, andOthers). The report analyses the COPD Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023. This report also includes pipeline analysis for few COPD drugs. Request free Sample of this Report @ http://azothanalytics.com/report/healthcare-pharma/global-copd-drugs-market-analysis-by-drug-type-combination-therapy-anticholinergics-beta-agonist-inhaled-corticosteroids-others-pipeline-drugs-by-region-by-country-2019-edition-forecast-to-2023-r29194 COPD Drugs Market Analysis
Visit us: http://azothanalytics.com/research/healthcare-pharma-c1
Global Hepatitis B Virus [HBV] Treatment Market: Opportunities and Forecast (...Matloob Hasan
The global Hepatitis B treatment market growth is backed by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Moreover, the global market growth is driven by the rising global healthcare expenditure, healthcare infrastructure development and changing lifestyle is expected to supplement the market growth during the forecast period.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others). The report analyses the Antifungal Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023.Visit us: http://azothanalytics.com/report/healthcare-pharma/global-antifungal-drugs-market-analysis-by-drug-class-azoles-echinocandins-polyenes-others-by-therapeutic-indications-candidiasis-aspergillosis-dermatophytosis-others-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28194
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Capsule Endoscopy Market Is Anticipated To Touch 886.3 Million In 2022: Grand...Amit M
The Global Capsule Endoscopy Market is expected to reach USD 886.3 million by 2022; according to a new study by Grand View Research, Inc. Increasing prevalence of colorectal cancer, GI diseases and growing demand for precise and accurate diagnostic tools are expected to drive the capsule endoscopy market.
Global Inflammatory Bowel Diseases (IBD) Drug Market Forecast 2017-2027Visiongain
For a report overview of this report please contact sara.peerun@visiongainglobal.com
(+44 (0) 20 7336 6100) or refer to our website:
https://www.visiongain.com/
https://www.visiongain.com/Report/1830/Global-Inflammatory-Bowel-Diseases-(IBD)-Drug-Market-Forecast-2017-2027
"The Global In Vitro Diagnostics (IVD) Market is calculated to reach $91.49 billion by 2024, at a CAGR of
6.01% during the forecast period 2019-2024. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories,
increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the
key factors driving the growth of the market."
Global Vascular Access Device Market: Opportunities and Forecast (2012-2022)AzothAnalytics
The report titled, “Global Vascular Access Device Market: Analysis By Type, By Mode of Insertion, By Region, By Country: Opportunities and Forecast (2012-2022) - By Type (PICC, CVC, Implantable Ports, Others), By Mode of Insertion (Subcutaneous, Intravenous)” has covered and analysed the potential of Global Vascular Access Device Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global vascular access device market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Biochip Market - Overview and Growth ReportSignitech
Global biochip market was valued at USD 7.63 billion in 2015. Presence of strong demand for proteomics - and genomics research-oriented products along with a comprehensive drug development pipeline is expected to drive growth in revenue.
Regenerative Medicines: Bone and Joint ApplicationsReportLinker.com
Provides a comprehensive overview of the global market for regenerative medicines for bone and joint applicationsOffers the background for demographics underlying the market for bone and joint productsContains global market forecasts for regenerative medicines for bone and joint applications, with trends and forecasts for growth through 2014Describes the leading bone and joint diseases and disorders using regenerative technologies, including incidence and current methods of treatmentDiscusses regulatory issues affecting regenerative medicine productsProfiles leading and emerging companies.
Liquid Biopsy Market Global Research Report Forecast to 2021-2026 | MarkNtel ...NarayanSharma67
According to MarkNtel Advisors’ research report titled “Global Liquid Biopsy Market Analysis, 2020”, the Global Liquid Biopsy market is anticipated to grow at a CAGR of around 26% during 2021-26F.
Next Generation Antibody Therapies World Industry 2014-2024Visiongain
For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website http://www.visiongain.com/Report/1210/Next-Generation-Antibody-Therapies-World-Industry-and-Market-2014-2024
Cell Line Development Market Size, Share & Trends Analysis Report by Product, By Source (Mammalian, Non-Mammalian), By Type of Cells, By Application, By Technology, And Segment Forecasts, 2012 - 2022
Global glycobiology market size, share & market forecast 2025TechSci Research
According to www.techsciresearch.com latest Report- Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines
Report URL- https://www.techsciresearch.com/report/glycobiology-market/4635.html
Global negative pressure wound therapy devices market was valued at US$ 1,227.0 million in 2015 and is forecast to grow to US$ 1,617.3 million by 2020 at a CAGR of 5.6% from 2016 to 2020.
Global Fatty Liver Disease Drugs Market:Opportunities and Forecast (2017-2022) AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Fatty Liver Disease Market on the basis of Type (Alcoholic Fatty Liver Disease or ALD), Non Alcoholic Fatty Liver Disease or NAFLD), By Alcoholic Fatty Liver Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By Non Alcoholic Fatty Liver Stages (Non Alcoholic Steatosis, Non Alcoholic Steatohepatitis or NASH), By Alcoholic Liver Disease Drug (Opiod Antagonist, Glucocorticoid, Pentoxifyline, Antioxidants, Granulocyte colony stimulating factor), By Non Alcoholic Fatty Liver Drug (Antioxidants Thiazolidinedione, Biguanides, Lipid Lowering agents, FXR receptor agonist, Elafibranoer), By Region (North America, Europe, Asia Pacific and ROW) and By Country (U.S., Canada , U.K., France, Germany, China, Japan, India, Brazil, South Africa and Saudi Arabia).
Link
http://azothanalytics.com/report/healthcare-pharma/global-fatty-liver-disease-drugs-market-by-type-ald-nafld-by-stages-of-ald-and-nafld-by-region-by-country-opportunities-and-forecast-2017-2022-r12115
Will reimbursement prove to be the biggest barrier as three gene therapies gain regulatory approval?
Datamonitor Healthcare has carried out a comprehensive analysis of gene therapy products in commercial development worldwide based on information derived from Pharmaprojects. The results have been analyzed to reveal trends in gene therapy technologies and approaches to the treatment of different diseases.
The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products – Glybera (uniQure), Imlygic (Amgen), and Strimvelis (GlaxoSmithKline) – have now received regulatory approval in Europe. While these approvals give some validation to gene therapy as a therapeutic strategy, doubts remain around their return on investment. The high upfront costs and residual uncertainty around the long-term benefits of gene therapy products are proving to be hurdles to wider access and reimbursement, but seem to have had a minimal impact on companies’ appetite to dive into this arena, with cancer and monogenic diseases proving to be the most popular indications for the development of gene therapy products.
For more information on this report visit https://pharmastore.informa.com/product/trends-gene-therapy/
In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026
For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website https://www.visiongain.com/Report/1279/Ophthalmic-Drugs-Market-Forecast-2014-2024
Global Endoscopy Devices Market Forecast (2013-2023)stella thomson
A comprehensive research report created through extensive primary research (inputs from industry experts. Visit us: http://azothanalytics.com/report/healthcare-pharma/global-endoscopy-devices-market-analysis-by-type-rigid-flexible-capsule-application-arthroscopy-bronchoscopy-colonoscopy-laparoscopy-gi-endoscopy-others-by-end-user-hospital-clinic-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28201
Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023) Matloob Hasan
Globally, the market for antidepressant drugs mask has been growing at a swift pace on the back of rising prevalence mental disorders, rising healthcare awareness and rising disposable incomes. Apart from these factors, rising healthcare facilities, increasing number of psychiatrist as well as surging number of hospital and clinics and burgeoning growth in Asia Pacific market is impelling growth in the market.
Global Vascular Access Device Market: Opportunities and Forecast (2012-2022)AzothAnalytics
The report titled, “Global Vascular Access Device Market: Analysis By Type, By Mode of Insertion, By Region, By Country: Opportunities and Forecast (2012-2022) - By Type (PICC, CVC, Implantable Ports, Others), By Mode of Insertion (Subcutaneous, Intravenous)” has covered and analysed the potential of Global Vascular Access Device Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global vascular access device market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Biochip Market - Overview and Growth ReportSignitech
Global biochip market was valued at USD 7.63 billion in 2015. Presence of strong demand for proteomics - and genomics research-oriented products along with a comprehensive drug development pipeline is expected to drive growth in revenue.
Regenerative Medicines: Bone and Joint ApplicationsReportLinker.com
Provides a comprehensive overview of the global market for regenerative medicines for bone and joint applicationsOffers the background for demographics underlying the market for bone and joint productsContains global market forecasts for regenerative medicines for bone and joint applications, with trends and forecasts for growth through 2014Describes the leading bone and joint diseases and disorders using regenerative technologies, including incidence and current methods of treatmentDiscusses regulatory issues affecting regenerative medicine productsProfiles leading and emerging companies.
Liquid Biopsy Market Global Research Report Forecast to 2021-2026 | MarkNtel ...NarayanSharma67
According to MarkNtel Advisors’ research report titled “Global Liquid Biopsy Market Analysis, 2020”, the Global Liquid Biopsy market is anticipated to grow at a CAGR of around 26% during 2021-26F.
Next Generation Antibody Therapies World Industry 2014-2024Visiongain
For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website http://www.visiongain.com/Report/1210/Next-Generation-Antibody-Therapies-World-Industry-and-Market-2014-2024
Cell Line Development Market Size, Share & Trends Analysis Report by Product, By Source (Mammalian, Non-Mammalian), By Type of Cells, By Application, By Technology, And Segment Forecasts, 2012 - 2022
Global glycobiology market size, share & market forecast 2025TechSci Research
According to www.techsciresearch.com latest Report- Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines
Report URL- https://www.techsciresearch.com/report/glycobiology-market/4635.html
Global negative pressure wound therapy devices market was valued at US$ 1,227.0 million in 2015 and is forecast to grow to US$ 1,617.3 million by 2020 at a CAGR of 5.6% from 2016 to 2020.
Global Fatty Liver Disease Drugs Market:Opportunities and Forecast (2017-2022) AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Fatty Liver Disease Market on the basis of Type (Alcoholic Fatty Liver Disease or ALD), Non Alcoholic Fatty Liver Disease or NAFLD), By Alcoholic Fatty Liver Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By Non Alcoholic Fatty Liver Stages (Non Alcoholic Steatosis, Non Alcoholic Steatohepatitis or NASH), By Alcoholic Liver Disease Drug (Opiod Antagonist, Glucocorticoid, Pentoxifyline, Antioxidants, Granulocyte colony stimulating factor), By Non Alcoholic Fatty Liver Drug (Antioxidants Thiazolidinedione, Biguanides, Lipid Lowering agents, FXR receptor agonist, Elafibranoer), By Region (North America, Europe, Asia Pacific and ROW) and By Country (U.S., Canada , U.K., France, Germany, China, Japan, India, Brazil, South Africa and Saudi Arabia).
Link
http://azothanalytics.com/report/healthcare-pharma/global-fatty-liver-disease-drugs-market-by-type-ald-nafld-by-stages-of-ald-and-nafld-by-region-by-country-opportunities-and-forecast-2017-2022-r12115
Will reimbursement prove to be the biggest barrier as three gene therapies gain regulatory approval?
Datamonitor Healthcare has carried out a comprehensive analysis of gene therapy products in commercial development worldwide based on information derived from Pharmaprojects. The results have been analyzed to reveal trends in gene therapy technologies and approaches to the treatment of different diseases.
The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products – Glybera (uniQure), Imlygic (Amgen), and Strimvelis (GlaxoSmithKline) – have now received regulatory approval in Europe. While these approvals give some validation to gene therapy as a therapeutic strategy, doubts remain around their return on investment. The high upfront costs and residual uncertainty around the long-term benefits of gene therapy products are proving to be hurdles to wider access and reimbursement, but seem to have had a minimal impact on companies’ appetite to dive into this arena, with cancer and monogenic diseases proving to be the most popular indications for the development of gene therapy products.
For more information on this report visit https://pharmastore.informa.com/product/trends-gene-therapy/
In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026
For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website https://www.visiongain.com/Report/1279/Ophthalmic-Drugs-Market-Forecast-2014-2024
Global Endoscopy Devices Market Forecast (2013-2023)stella thomson
A comprehensive research report created through extensive primary research (inputs from industry experts. Visit us: http://azothanalytics.com/report/healthcare-pharma/global-endoscopy-devices-market-analysis-by-type-rigid-flexible-capsule-application-arthroscopy-bronchoscopy-colonoscopy-laparoscopy-gi-endoscopy-others-by-end-user-hospital-clinic-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28201
Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023) Matloob Hasan
Globally, the market for antidepressant drugs mask has been growing at a swift pace on the back of rising prevalence mental disorders, rising healthcare awareness and rising disposable incomes. Apart from these factors, rising healthcare facilities, increasing number of psychiatrist as well as surging number of hospital and clinics and burgeoning growth in Asia Pacific market is impelling growth in the market.
Global Animal Antibiotics and Antimicrobials Market (2017-2022) AzothAnalytics
The global Animal Antibiotics & Antimicrobials industry has been driven by the rising demand for animal derived food products and increasing healthcare expenditure on pets due to rising pet ownership. Globally, the growth in Animal Antibiotics & Antimicrobials market is driven by growing middle class population.
http://azothanalytics.com/report/healthcare-pharma/global-animal-antibiotics-and-antimicrobials-market-analysis-product-type-delivery-type-type-of-animals-company-analysis-regional-and-country-analysis-2017-2022-r14142
Global Animal Antibiotics and Antimicrobials Market (2017-2022) geeti chauhan
Globally, the growth of the Animal Antibiotics & Antimicrobials market is driven by increasing trend of pet humanization resulting in higher pet ownerships coupled with increasing animal health awareness, significant improvement in animal healthcare facilities and rising demand for animal derived food products which is propelling the growth of the Animal Antibiotics & Antimicrobials market worldwide. Moreover, the market is getting consolidated in terms of recent mergers and acquisition where the major players are strengthening their product portfolios and expanding their geographical reach.
According to Azoth Analytics research report, "Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022) – By Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins, Others), By Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others), By Type of Animals (Farm Animals, Companion Animals)”, is projected to exhibit a CAGR of over ~4.24% during 2017 – 2022, largely driven by the increase in spending of pet owners towards their pet health, growing demand for animal derived protein resulting in increasing farm sizes and animal population. It has been estimated by OECD that the consumption of meat will be 373 million metric tons by 2030 and 465 million tons by 2050 resulting in higher meat production. Many countries are shifting their focus to integrate meat production as a part of mainstream economic activity resulting in expanding farm sizes for the purpose of exports.
Generally, the risk of spread of zoonotic diseases increases with rising pet ownership and growing demand for animal derived food products resulting in the increasing usage of antibiotics & antimicrobials to prevent the further spread of the disease.
APAC is predicted to grow at higher rate during the year 2017-2012F, which is mainly driven by the increase in ownership of pets along with the rising demand for animal derived food products and growing preference for better animal healthcare products.
Tetracycline accounts for 43.85% of global animal antibiotics & antimicrobials market and anticipated to grow at significant rate during forecast period owing to the applicability to farm as well as companion animals along with the multi-purpose usage. Premixes accounts for more than x% of the total animal antibiotics & antimicrobials market and expected to continue dominating the global market during the forecast period with positive growth rate.
Our consulting and research services have been tailored for your requirements and your company as a way to explore growth plans and strategies. We do not stick to the one-size-fits-all approach.
Global Medical Sterilization Equipment Market (2017 Edition): Forecast to 2022AzothAnalytics
Among the modes of sterilization, low temperature sterilization equipment is projected to witness fastest growth. Advent of technologically complex and intricate medical devices is anticipated to boost the global market of low temperature sterilization solutions in the forecast period. Among the regions, North America followed by Asia Pacific is predicted to advance at the highest rate, mainly driven by large population base, rapid economic development as well as swiftly rising number of surgical procedures. While there are associated guidelines on sternly maintaining proper sterilization standards in developed regions, there is an increasing awareness pertaining to maintaining hygienic standards within healthcare facilities in developing regions, thereby, contributing towards the market growth in regions such as Asia Pacific and Middle East. Contract sterilization services have been gaining major traction as the next major development in the industry; however, there are certain challenges that will need to be addressed. Stringent regulations regarding product approval causes delay in the manufacturing of new sterilization device and is responsible for hampering the growth of the medical sterilization equipment market.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) Visit us: http://azothanalytics.com/report/healthcare-pharma/global-nuclear-medicine-market-analysis-by-product-type-diagnostic-therapeutic-by-diagnostic-nuclear-medicine-type-by-therapeutic-nuclear-medicine-type-by-indication-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28197
Sample global sterile injectables market reportMatloob Hasan
According to Azoth Analytics research report, “Global Sterile Injectables Market- By Molecule Type- (Biologic, Small Molecule), By Drug Type- (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin, Others), By Indications- (Oncological Disorders, Cardiovascular Disorders. Neurological Disorders, Infectious Disorders, Metabolic Disorders, Musculoskeletal Disorders, Others), By Distribution Channel- (Hospital Pharmacy, Retail Pharmacy, E-commerce), By Region (North America, Europe, Asia Pacific, Rest of the world) and By Country (U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia): (2018-2023)”: global market is projected to display a robust growth represented by a CAGR of 6.39% during 2018 – 2023.
Global antibody drug conjugate market & pipeline insight2020KuicK Research
" Global Antibody Drug Conjugate Market & Pipeline Insight 2020" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
Download Global antibody drug conjugate market & pipeline insight2020KuicK Research
\" Global Antibody Drug Conjugate Market & Pipeline Insight 2020\" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
Global Schizophrenia Drug Market, By Type (Paranoid Schizophrenia, Hebephrenic Schizophrenia, Catatonic Schizophrenia and Undifferentiated Schizophrenia), By Treatment (Oral and Injectable), By Therapeutic Class (Second Generation Antipsychotics, (Risperdal (Risperidone), Invega (Paliperidone), Zyprexa (Olanzapine), Geodon (Ziprasidone), Seroquel (Quetiapine), Latuda (Lurasidone)) Third Generation Antipsychotics and Other Therapeutic Classes), By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Market Trends, Analysis, and Forecast Till 2029.
Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR o...ankitakalvankar
Schizophrenia Drug Market, By Type (Paranoid Schizophrenia, Hebephrenic Schizophrenia, Catatonic Schizophrenia and Undifferentiated Schizophrenia), By Treatment (Oral and Injectable), By Therapeutic Class (Second Generation Antipsychotics, (Risperdal (Risperidone), Invega (Paliperidone), Zyprexa (Olanzapine), Geodon (Ziprasidone), Seroquel (Quetiapine), Latuda (Lurasidone)) Third Generation Antipsychotics and Other Therapeutic Classes), By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Market Trends, Analysis, and Forecast Till 2029.
Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR o...ankitakalvankar
Schizophrenia Drug Market, By Type (Paranoid Schizophrenia, Hebephrenic Schizophrenia, Catatonic Schizophrenia and Undifferentiated Schizophrenia), By Treatment (Oral and Injectable), By Therapeutic Class (Second Generation Antipsychotics, (Risperdal (Risperidone), Invega (Paliperidone), Zyprexa (Olanzapine), Geodon (Ziprasidone), Seroquel (Quetiapine), Latuda (Lurasidone)) Third Generation Antipsychotics and Other Therapeutic Classes), By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Market Trends, Analysis, and Forecast Till 2029.
Clinical Decision Support Systems (CDSS) Industry Report, 2018 to 2024Signitech
The global clinical decision support systems (CDSS) market size was valued at USD 471.96 million in 2016. Rising demand for quality care and integrated reliable technical solutions is one of the key trends escalating market growth.
Global cancer antibody drug conjugates market and pipeline insight 2022KuicK Research
“Global Cancer Antibody Drug Conjugate Market and Clinical Pipeline Insight 2022” report highlights:
Impetus of Antibody Drug Conjugates
Mechanism of Cancer Antibody Drug Conjugates
Global Cancer Antibody Drug Conjugate Clinical Pipeline Overview
Marketed Cancer Antibody Drug Conjugate Clinical Insight
Global Cancer Antibody Drug Conjugate Pipeline by Company, Indication , Mode of Action, Formulation and Phase
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...Grand View Research
Aminoglycosides Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral), By Application (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis) And Segment Forecasts To 2022
Global Alzheimer's Drug Market Trends Opportunities and Forecasts (2015-2020)AzothAnalytics
The brochure of the report comprises of various dynamics of the Global Alzheimer's Drug Market:
The report includes an in depth analysis of:
Market Size and Share:By Type,Region,Age Group
Similar to Migraine Pipeline Drugs Market Assessment– Forecast to 2022 (20)
Global Seeds Market (2022 Edition) - Trends and Forecast Analysis Till 2028 AzothAnalytics
The Global Seeds Type Market was valued at USD12.88 Billion in the year 2021 with the Americas region leading the regional market share. For more: info@azothanalytics.com
Global Quick Service Restaurant (QSR) Market Factbook (2022 Edition)AzothAnalytics
Further the report provides an assessment of positioning of leading brands (McDonalds, Starbucks, KFC, Subway, Taco Bell, Pizza Hut, Tim Hortons, Burger King, Wendy’s, Domino’s) in the QSR market. For more info@azothanalytics.com
Global Health Beverage Market - By Region, By Country (2018 Edition): Forecas...AzothAnalytics
Among the types of beverages, bottled water is projected to witness growth at the fastest pace over the rising demand for clean water across various parts of the globe. Usage of bottled water has been rising on the back of increasing usage in cocktails and other health ingredients infused drinks. Additionally, rising number of patients of water borne diseases is backing the market for bottled water. Among the regions, Asia Pacific is expected to grow at the fastest rate, mainly driven by large population base, increasing affordability backed by rise the per capita income and increasing influx of a diversified range of health beverages. Moreover, increasing number of gym memberships is propelling a rise in the demand for sports and probiotic beverages. Furthermore, growth in the number of private labels and home grown brands is backing the rise in the market value in the APAC region.
Global Water Purifier Market (2018 Edition): Forecast to 2022 AzothAnalytics
The demand for water purifiers across the globe has been steadily rising due to the growing need to use water that is free from contamination for a wide range of applications including drinking, cooking, industrial processing, sanitation & sterilization etc. The rising population especially in developing countries, the discharge of industrial waste directly into surface water, contamination of ground water with chemicals, aging of drainage pipes and poor water management and conservation efforts have resulted in a sharp decline in the quality of water that is supplied through public networks. The contamination of water with dissolved solids, viruses and bacteria not only limits the usefulness of the water for use in irrigation, commercial activities and industrial operations but the consumption of such water results in the spread of water borne diseases including diarrhea, cholera, dysentery etc especially in villages where people are dependent on wells and public taps for water supply as well as in industrial centers where untreated sewage and factory waste are often dumped into nearby water bodies. Consumers across the globe are becoming increasingly sensitized to the issue of water contamination and have begun to increasingly rely upon water purifiers to remove harmful impurities from water.
Global Fundus Camera Market: By Region, By Country (2018 Edition) - Forecast ...AzothAnalytics
Globally, the market for fundus camera has been growing at a swift pace on the back of rising prevalence of retinal disorders, rising healthcare awareness and rising disposable incomes. Apart from these factors, rising eye care facilities in hospitals, increasing number of ophthalmologist as well as surging number of hospital and clinics drive high demand of fundus camera.
Global Intravenous (IV) Iron Drugs Market: Forecast to 2022 AzothAnalytics
Globally, the market for diesel generator has been growing at a swift pace on the back of increasing demand for electricity across the globe, increasing number of blackouts due to natural calamities and overloading of power grids. Besides these factors, rising application in industrial and commercial sectors and inefficient electricity generation and transmission system is impelling growth in the market.
Global Oilfield Specialty Chemical Market: Forecast to 2022 AzothAnalytics
Specialty oilfield market is likely to witness substantial growth over the forecasted period owing to increasing application in cementing, drilling, production and Well Stimulation. Increasing crude oil production coupled with growing demand from enhanced oil recovery application is anticipated to augment specialty oilfield chemicals market growth. In addition, increasing deep drilling and ultra-deep drilling activities for oil and gas have been driving the market over the past few years and trend is expected to continue over the forecast period.
Global Cervical Cancer Diagnostics: Forecast to 2022AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market, Analysis By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (Below 35 years and 35 years & above), By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, Germany, U.K, China, India, Mexico and Brazil).
Global Anti-Pollution Mask Market: Opportunities and Forecast (2017-2022)AzothAnalytics
Globally, the market for anti-pollution mask has been growing at a swift pace on the back of rising prevalence of air borne disease, rising healthcare awareness and rising disposable incomes. Apart from these factors, technological advancements in air mask filters and burgeoning growth in Asia Pacific market is impelling growth in the market.
Global Mosquito Repellent Market (2017 Edition)AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Mosquito Repellent Market on the basis of Analysis By Product Type (Coils, Liquid Vaporizers, Sprays/Aerosol, Mats, Cream & Oil, Others), By Channel of Distribution (Retail Stores – Large, Small, Specialty; Online), By Region - North America, Europe, Asia Pacific and LAMEA, and By Country - US, Canada, Italy, France, China, India, Thailand, South Africa, Brazil and Colombia.
http://azothanalytics.com/report/consumer-retail/global-mosquito-repellent-market-by-type-coils-liquid-vaporizers-sprays-mats-cream-oil-sales-channel-market-share-2017-edition-forecast-to-2022-r14133
Global Peripheral Nerve Repair Market: Opportunities and Forecast (2017-2022) AzothAnalytics
The report titled “Global Peripheral Nerve Repair Market Analysis By Technique (Direct Repair, Nerve Grafting, Nerve Conduits, Others), By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (North America, Europe, Asia Pacific, RoW); By Country (US, Canada, Germany, France, U.K., China, Australia, South Africa, Brazil) has covered and analysed the potential of Global Peripheral Nerve Repair Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global peripheral nerve repair market. Additionally, the report also highlights market entry strategies for various companies across the globe.
http://azothanalytics.com/report/healthcare-pharma/global-peripheral-nerve-repair-market-analysis-by-technique-direct-repair-nerve-grafting-nerve-conduits-others-by-region-by-country-opportunities-and-forecast-2017-2022-r13131
North America Insulated Copper Tubes Market: Opportunities and Forecast (2017...AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of North America Insulated Copper Tube Market (By End Use Application, By Country): Opportunities and Forecasts (2011-2021) - (By End Use Application – HVAC, Refrigeration, Plumbing, Industrial, Solar system, others), (By Country – United States, Canada, Mexico: (2011-2021)” North America insulated copper tube market is anticipated to advance at a moderate CAGR of 1.63% during 2017-2021, majorly driven by rising residential construction activities, increasing construction expenditure, technological advancements and recovery in the prices of Copper metal.
http://azothanalytics.com/report/construction-manufacturing/north-america-insulated-copper-tubes-market-analysis-by-application-by-country-opportunities-and-forecast-2017-2021-r12122
Global Water Pipeline Leak Detection System (LDS) Market: Analysis and Foreca...AzothAnalytics
The report titled, “Global Water Pipeline Leak Detection System (LDS) Market By Technology, By Equipment, By Type, By Location of Application, By Region, By Country – Analysis and Forecast (2017 Edition) - By Technology (Equipment, Inspection Service), By Equipment (Acoustic, Non Acoustics), By Type ( Continuous, Non Continuous), By Location of Application (Underwater, Above the ground, Underground)” has covered and analysed the potential of Global Water Pipeline Leak Detection System Market and provides statistics and information on market size, shares and growth factors.
http://azothanalytics.com/report/energy-utilities/global-water-pipeline-leak-detection-system-lds-market-by-technology-by-equipment-by-type-by-location-of-application-by-region-by-country-analysis-and-forecast-2017-edition-r12123
Global Pharmaceutical Plastic Packaging Market: Opportunities and Forecast (2...AzothAnalytics
The report titled, “Global Pharmaceutical Plastic Packaging Market - By Type, By Drug Delivery, By Polymer Type, By Packaging Type, By Region, By Country: Opportunities and Forecast (2017-2022) - – By Type (Rigid & Packaging), By Packaging Type (Plastic Bottles, Blister Pack, Caps & Closures, Prefilled Syringe, Others), By Drug Delivery (Oral, Parenteral, Inhalation, Transdermal), By Polymer (Polypropylene, PVC, HDPE, LDPE, Polyester, Polystyrene, Others)”, has covered and analysed the potential of pharmaceutical plastic packaging market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the pharma packaging market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Global Large Format Ceramic Panel Market: Opportunities and Forecast (2014-2022)AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Large Format Ceramic Panel Market- By Volume and Value; By Application (Flooring, Interior Wall, Exterior Cladding and Countertops), By Thickness (3mm &below,5 to 9mm, 9.1 to12mm and 12mm & above ), By Region (North America, Europe, Asia Pacific, G.C.C and ROW) and By Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, China, India, Indonesia, Saudi Arabia, Qatar and UAE).
Link
http://azothanalytics.com/report/construction-manufacturing/global-large-format-ceramic-panel-market-analysis-by-type-of-application-flooring-interior-wall-exterior-wall-cladding-countertop-by-thickness-3mm-below-5-9-mm-91-12-mm-20-mm-above-by-region-by-country-opportunities-and-forecast-2014-2022-r12105
Global Industrial Lubricant Market: Opportunities and Forecast (2017-2022)AzothAnalytics
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Industrial Lubricant Market By Product Base Oil (Mineral, Synthetic, Bio-based), By Type (Process Oil, General Industrial Lubricants, Metal Working Fluid, Industrial Engine Oil, Others), By Industry Application (Automotive, Power, Marine, Manufacturing, Mining, Others), By Region (North America, South America, Europe, Asia Pacific, Middle East & Africa) and By Country (U.S., Canada, Brazil, Germany, France, U.K., China, India, Japan, Egypt, Saudi Arabia).
Rapid industrialization and increasing demand has raised the production rate in almost every manufacturing company, globally. Industries are now therefore more concerned with the maintenance of machinery to provide better quality product. This has escalated the demand of lubricants. Moreover with the need of enhanced lubricants to work under extreme conditions, its new technology will drive the market in coming future.Global Industrial Lubricant Market: Analysis By Product Base Oil (Mineral, Synthetic, Bio-based), By Type (Process Oil, General Industrial Lubricants, Metal Working Fluid, Industrial Engine Oil, Others), By Industry Application (Automotive, Power, Marine, Manufacturing, Mining, Others), By Region (North America, South America, Europe, Asia Pacific, Middle East & Africa), By Country (U.S., Canada, Brazil, Germany, France, U.K., China, India, Japan, Egypt, Saudi Arabia): (2012-2022).
According to Azoth Analytics research report, “Global Industrial Lubricant Market: Analysis By Product Base Oil, By Type, By Industry Application, By Region, By Country: Opportunities and Forecast (2017-2022) - By Base Oil (Mineral, Synthetic, Bio-based), By type (Process Oil, General Industrial Lubricants, Metal Working Fluid, Industrial Engine Oil), By Application (Automotive, Power, Marine, Manufacturing, Mining)”, global market is projected to display a growth represented by a CAGR of 3.03% during 2017 – 2022, chiefly driven by the rapid growth in industries and automotive sector. The new emerging industries like Mining, Marine, etc. along with the increase in manufacturing companies, both in developed and developing countries are driving the demand of high quality lubricants due to the growing presence of synthetic and bio lubricants in the market.
For more information, kindly mail me at azothanalytics7@gmail.com
Global low -e glass market by type by application - opportunities and forecas...AzothAnalytics
Global Low E-Glass Market - By Type (Single, Double, Triple), By Application (Residential, Commercial): Analysis By Region, By Country - Opportunities and Forecast (2016-2021)
- By Type (Single Low E-Glass, Double Low E-Glass, Triple Low-E Glass); By Application (Residential, Commercial, Others), By Region (North America, Europe, APAC, ROW), By Country (US, Canada, Germany, UK, China, India, Saudi Arabia, Brazil, South Africa)
Link
http://azothanalytics.com/report/construction-manufacturing/global-low-e-glass-market-by-type-single-double-triple-by-application-residential-commercial-analysis-by-region-by-country-opportunities-and-forecast-2016-2021-r3079
By Segments – EHR, Wireless, Mobile; By Type – Applications, Sensor, Functionality, End-Use; By Region – North America, Latin America, Europe, APAC, RoW; By Country; Company Profiles, Recommendations
By Drug Class -Endothelin Receptor Antagonists, Prostacyclin & Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others; By Region-North America, Europe, APAC, Latin America, MEA; By Country- USA, Canada, UK, Germany, Japan, Brazil, South Africa
By Type (Heterogeneous, Homogeneous and Enzymatic Catalyst); By Raw Material (Zeolites, Metals and Chemical Compounds); By Application (Environmental, Refinery, Polymer and Chemical Process Catalyst); By Region (North America, South America, APAC, Europe, Middle East and Africa); By Country (US, Canada, Germany, China, India, Brazil, Japan)
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Migraine Pipeline Drugs Market Assessment– Forecast to 2022
1. (c) AZOTH Analytics
Migraine Pipeline Drugs Market Assessment: Industry
Analysis, Pipeline Review, Clinical Trials, Market Potential –
Forecast to 2022
• Global Migraine Pipeline Drugs Assessment –
Review, Potential, Clinical Trials
• Global Migraine Drugs Share By Type – Acute and
Prophylaxis
• Company Analysis
January 2018
2. (c) AZOTH Analytics
Global Migraine Pipeline Drugs
Assessment
Global Migraine Drugs Market
(2012-2016), By Value
Global Migraine Drugs Market
(2017-2022), By Value
Breakdown-By Type - Acute and
Prophylaxis)
Global Migraine Drugs Market
(2012-16), By Value
Global Migraine Drugs Market
(2017-22), By Value
Global Coverage Country Coverage
Migraine Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market
Potential – Forecast to 2022
Migraine Drugs Market, By Value
(2012-2016)
Migraine Drugs Market, By Value
(2017-2022)
United States
United Kingdom
Japan
France
Italy
Germany
Pipeline Drugs Coverage
Migraine Drugs Market Forecast -
By Value (2018-2022)
Drug X-1
Drug X-2
Drug X-3
Drug X-4
Drug X-5
Drug X-6
Drug X-7
Company Coverage
Product Benchmarking
Policy and Regulatory Landscape
Financial Analysis
Sales
EBITDA
Business Strategy
Amgen
Allergan
Eli Lilly
Alder Pharmaceuticals
Teva Pharmaceuticals
Vernalis
Pfizer
Impax Laboratories
Glaxo Smithkline
Global Coverage
Country Coverage
Scope of the Study Migraine Pipeline Drugs Assessment
Global Migraine Drugs Market – By Type (Acute and Prophylaxis)
2
3. (c) AZOTH Analytics
Table of Content
3
S.No Particulars Page No.
1. Research Methodology 16
2. Executive Summary 17
3. Migraine - An Overview 18
3.1 Symptoms of migraine 18
3.2 Stages of Migraine 19
3.3 Types of Migraine 20
3.4 Types of migraine on the basis of frequency of occurrence 24
4. Treatment of Migraine 25
4.1 Goal of Migraine Treatment 26
4.2 Treatment of Migraine – Pharmacological and Non-Pharmacological 26
4.2.1 Pharmacological treatment of migraine 27
4.2.2 Pharmacological - Abortive 28
4.2.3 Pharmacological - Preventive 30
4. (c) AZOTH Analytics
Table of Content
4
S.No Particulars Page No.
4.2.4 Non-Pharmacological Treatment of Migraine 33
4.2.5 Non- Pharmacological - Surgical 34
4.2.6 Non- Pharmacological – Non-Surgical 35
5. Anti Migraine Pipeline Drugs 38
5.1 Anti-Migraine Pipeline Drugs (According to Mechanism of Working) 39
5.2 Anti Migraine Pipeline Drugs (Ergotamine) – Drug X-1 40
5.2.1 Description 41
5.2.2 Regulatory Milestones 42
5.2.3 Advantages & Disadvantages 43
5.2.4 Product Profile & Expected Launch 44
5.2.5 Clinical Trials and Status 45
5.2.6 Pivotal Clinical Trials and Results 46
5.2.7 Drug X-1 – Global Market Potential 48
5.2.8 Drug X-1 - 7Ps Analysis 50
5. (c) AZOTH Analytics
Table of Content
5
S.No Particulars Page No.
5.3 Anti Migraine Pipeline Drugs (Anti-5HT Receptor Agonist) – Drug X-2 51
5.3.1 Description 52
5.3.2 Regulatory Milestones 53
5.3.3 Advantages & Disadvantages 54
5.3.4 Product Profile & Expected Launch 55
5.3.5 Clinical Trials and Status 56
5.3.6 Pivotal Clinical Trials and Results 58
5.3.7 Drug X-2 – Global Market Potential 60
5.3.8 Drug X-2 – 7Ps Analysis 62
5.4 Anti Migraine Pipeline Drugs (Anti CGRPs) 63
5.5 Anti Migraine Pipeline Drugs (Anti CGRPs) – By Drug 66
5.6 Anti Migraine Pipeline Drugs (CGRP Antagonist) - Drug X-3 67
5.6.1 Description 68
5.6.2 Regulatory Milestones 69
5.6.3 Advantages & Disadvantages 70
6. (c) AZOTH Analytics
Table of Content
6
S.No Particulars Page No.
5.6.4 Product Profile & Expected Launch 71
5.6.5 Clinical Trials and Status 72
5.6.6 Pivotal Clinical Trials and Results 73
5.6.7 Drug X-3 – Global Market Potential 75
5.6.8 Drug X-3 – 7Ps Analysis 77
5.7 Anti Migraine Pipeline Drugs (Anti-CGRP Mab) - Drug X-4 80
5.7.1 Description 81
5.7.2 Regulatory Milestones 82
5.7.3 Advantages & Disadvantages 83
5.7.4 Product Profile & Expected Launch 84
5.7.5 Clinical Trials and Status 85
5.7.6 Pivotal Clinical Trials and Results 86
5.7.7 Drug X-4 – Global Market Potential 90
5.7.8 Drug X-4 – 7Ps Analysis 92
7. (c) AZOTH Analytics
Table of Content
7
S.No Particulars Page No.
5.8 Anti Migraine Pipeline Drugs (Anti-CGRP Mab) - Drug X-5 93
5.8.1 Description 94
5.8.2 Regulatory Milestones 95
5.8.3 Advantages & Disadvantages 96
5.8.4 Product Profile & Expected Launch 97
5.8.5 Clinical Trials and Status 98
5.8.6 Pivotal Clinical Trials and Results 100
5.8.7 Drug X-5 – Global Market Potential 103
5.8.8 Drug X-5 – 7Ps Analysis 105
5.9 Anti Migraine Pipeline Drugs (Anti-CGRP Mab) - Drug X-6 106
5.9.1 Description 107
5.9.2 Regulatory Milestones 108
5.9.3 Advantages & Disadvantages 109
5.9.4 Product Profile & Expected Launch 110
8. (c) AZOTH Analytics
Table of Content
8
S.No Particulars Page No.
5.9.5 Clinical Trials and Status 111
5.9.6 Pivotal Clinical Trials and Results 113
5.9.7 Drug X-6 – Global Market Potential 115
5.9.8 Drug X-6 – 7Ps Analysis 117
5.10 Anti Migraine Pipeline Drugs (Anti-CGRP Mab) - Drug X-7 118
5.10.1 Description 119
5.10.2 Regulatory Milestones 120
5.10.3 Advantages & Disadvantages 121
5.10.4 Product Profile & Expected Launch 122
5.10.5 Clinical Trials and Status 123
5.10.6 Pivotal Clinical Trials and Results 125
5.10.7 Drug X-7 – Global Market Potential 127
5.10.8 Drug X-7 – 7Ps Analysis 129
9. (c) AZOTH Analytics
Table of Content
9
S.No Particulars Page No.
6. Global Migraine Drugs Market: Growth and Forecast 130
6.1 By Value (2012-2016) 131
6.2 By Value (2017-2022) 132
7. Global Migraine Drugs Market-By Type 135
7.1 Global Migraine Drugs Market, By Type : Breakdown (%) 135
7.1.1 Global Migraine Drugs Market- By Type: 2016 (%) 136
7.1.2 Global Migraine Drugs Market – By Type: 2022 (%) 137
7.2 Global Migraine Drugs Market- By Acute 139
7.2.1 By Value (2012-2016) 139
7.2.2 By Value (2017-2022) 139
7.3 Global Migraine Drugs Market- By Prophylaxis 140
7.3.1 By Value (2012-2016) 140
7.3.2 By Value (2017-2022) 140
10. (c) AZOTH Analytics
Table of Content
S.No Particulars Page No.
8. Global Migraine Drugs Market: Country Analysis (U.S, U.K, Japan, France, Italy, Germany, ROW) 141
8.1 U.S. Migraine Drugs Market, By Value (2012-2022) 142
8.2 U.K. Migraine Drugs Market, By Value (2012-2022) 144
8.3 Japan Migraine Drugs Market, By Value (2012-2022) 146
8.4 France Migraine Drugs Market, By Value (2012-2022) 148
8.5 Italy Migraine Drugs Market, By Value (2012-2022) 150
8.6 Germany Migraine Drugs Market, By Value (2012-2022) 152
8.7 ROW Migraine Drugs Market, By Value (2012-2022) 154
9. Market Dynamics 155
9.1 Migraine Drug Market Drivers 156
9.2 Migraine Drug Market Challenges 160
10. Company Profile 162
10.1. Amgen 163
10
12. (c) AZOTH Analytics
List of Figures
Figure No. Figure Title Page No.
Figure 1: 2 hour pain relief & pain free rates in patients treated with LEVADEX (MAP0004) compared to placebo (1st
pivotal trial)
47
Figure 2: Improvement at two hours in people who took LEVADEX compared to Placebo (2nd pivotal trial) 47
Figure 3: Global Drug X-1 Market Size, By Value, Forecast, 2019-2022 (USD Billion) 48
Figure 4: Percentage of patients achieving primary end point 59
Figure 5: Percentage of patients achieving secondary endpoint 59
Figure 6: Global Drug X-2 Market Size, By Value, Forecast, 2019-2022 (USD Million) 60
Figure 7: Efficacy in 2 hour pain freedom 74
Figure 8: Global Drug X-3 Market Size, By Value, Forecast, 2019-2022 (USD Billion) 75
Figure 9: Reduction in Monthly migraine days – weeks 1 through 12 87
Figure 10: Percentage of patients with ≥75% reduction in number of migraine days – weeks 1 through 24 88
Figure 11: Percentage of patients with 100% response rate (no migraine in any given month) – months 1 through 6 89
Figure 12: Global Drug X-4 Market Size, By Value, Forecast, 2019-2022 (USD Million) 90
Figure 13: Global Drug X-5 Market Size, By Value, Forecast, 2019-2022 (USD Million) 103
Figure 14: Global Drug X-6 Market Size, By Value, Forecast, 2019-2022 (USD Million) 115
Figure 15: Monthly migraine days reduction vs placebo in previous prophylactic drugs failure group 125
Figure 16: Reduction in days using acute pain medications in recent drug overuse group 125
Figure 17: Global Drug X-7 Market Size, By Value, Forecast, 2019-2022 (USD Million) 127
Figure 18: Global Migraine Drugs Market Size, By value, 2012-2016 (USD Billion) 131
Figure 19: Global Migraine Drugs Market Size, By Value, Forecast, 2017-2022 (USD Billion) 132
12
13. (c) AZOTH Analytics
List of Figures
Figure No. Figure Title Page No.
Figure 20: Global consumption of chocolate confectionary, By volume (in 1000 metric tones) 134
Figure 21: Global Migraine Drugs Market Share, By Type, 2016 (%) 136
Figure 22: Global Migraine Drugs Market Share, By Type, 2022 (%) 137
Figure 23: Global Migraine Drugs Market, By Acute, By Value, 2012-2016 (USD Million) 139
Figure 24: Global Migraine Drugs Market, By Acute, By Value, 2017-2022 (USD Million) 139
Figure 25: Global Migraine Drugs Market, By Prophylaxis, By Value, 2012-2016 (USD Million) 140
Figure 26: Global Migraine Drugs Market, By Prophylaxis, By Value, 2017-2022 (USD Million) 140
Figure 27: U.S. Migraine Drugs Market, By Value, 2012-2016 (USD Billion) 142
Figure 28: U.S. Migraine Drugs Market, By Value, 2017-2022 (USD Billion) 142
Figure 29: U.S Adult Migraine Patients, In Percentage 143
Figure 30: U.S Migraine Patients, By gender, In Percentage 143
Figure 31: U.K Migraine Drugs Market, By Value, 2012-2016 (USD Billion) 144
Figure 32: U.K. Migraine Drugs Market, By Value, 2017-2022 (USD Billion) 144
Figure 33: U.K. Migraine Patient, In Percentage 145
Figure 34: NHS Budget for mental illness, In Billion 145
Figure 35: Japan Migraine Drugs Market, By Value, 2012-2016 (USD Billion) 146
Figure 36: Japan Migraine Drugs Market, By Value, 2017-2022 (USD Billion) 146
Figure 37: Japan Migraine Patient out of total population, In Percentages 147
Figure 38: France Migraine Drugs Market, By Value, 2012-2016 (USD Billion) 148
Figure 39: France Migraine Drugs Market, By Value, 2017-2022 (USD Billion) 148
13
14. (c) AZOTH Analytics
List of Figures
Figure No. Figure Title Page No.
Figure 40: France Migraine Patient, In Percentage 149
Figure 41: Unemployment rate in France in percentage 149
Figure 42: Italy Migraine Drugs Market, By Value, 2012-2016 (USD Billion) 150
Figure 43: Italy Migraine Drugs Market, By Value, 2017-2022 (USD Billion) 150
Figure 44:
Italy Migraine Patient out of total population, In Percentages
151
Figure 45: Italy Unemployment rate, In Percentages 151
Figure 46: Germany Migraine Drugs Market, By Value, 2012-2016 (USD Billion) 152
Figure 47: Germany Migraine Drugs Market, By Value, 2017-2022 (USD Billion) 152
Figure 48: Germany Migraine Patient out of total population, In Percentages 153
Figure 49: First Time asylum application, In Number 153
Figure 50: ROW Migraine Drugs Market, By Value, 2012-2016 (USD Billion) 154
Figure 51: ROW Migraine Drugs Market, By Value, 2017-2022 (USD Billion) 154
Figure 52: ROW Migraine Drugs Market, By Value, 2017-2022 (USD Billion) 165
14
15. (c) AZOTH Analytics
Research Methodology
For our study of Migraine Drugs Market, we have conducted comprehensive secondary research
followed by an extensive primary research. In the process of secondary research, we have scrutinized
industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson
Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have
interviewed various industry experts across the value chain of the Migraine Drug industry.
For evaluating the market size of pipeline drugs, both primary and secondary research has been
conducted to validate the launch date, anticipated price and growth in the number of patients.
Market size of the actual period (2012-2016) has been evaluated on the basis of growth trends of
the industry in the last five years, and confirming the findings through primary research. Annual
reports of the companies are scanned to further validate the market size and to estimate the size of
migraine drugs. All the relevant data points/ statistics in the forecast period are validated through
relevant and reliable primary sources.
Report Focus: Global Migraine Drugs Market
- Migraine Pipeline Drugs (Drug X-1, X-2, X-3, X-4, X-5, X-6, X-7)
- By Type (Acute and Prophylaxis)
- By Country (U.S., U.K, Japan, France, Italy, Germany)
- Company Coverage (Amgen, Allergan, Eli Lilly, Alder Pharmaceuticals, Teva Pharmaceutical, Vernalis,
Pfizer, Impax Laboratories, Glaxo Smithkline)
16
16. (c) AZOTH Analytics
2019 2020 2021 2022
Source: Azoth Analytics Estimates
CAGR 2019-2022
X%
Figure 14: Global Drug X-1 Market Size, By Value, Forecast, 2019-2022 (USD Million)
Global Fremanezumab Market
115
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
18. (c) AZOTH Analytics
Global Migraine Drugs Market: Sizing and Growth (2012-2016)
Source: Azoth Analytics Estimates
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Increase in Global Stress levels coupled with growing awareness regarding migraine and availability of its
drugs propelled growth in migraine drugs market.
2012 2013 2014 2015 2016
Figure 18: Global Migraine Drugs Market Size, By value, 2012-2016 (USD Billion)
CAGR 2012-2016
X%
131
19. (c) AZOTH Analytics
Global Heart Valve Replacement Devices Market, By Value
Figure 27: U.S. Migraine Drugs Market, By Value,
2012-2016 (USD Billion)
Source: Azoth Analytics Estimates
CAGR 2012-2016
X%
CAGR 2017-2022
X%
Figure 28: U.S. Migraine Drugs Market, By Value,
2017-2022 (USD Billion)
U.S. Migraine Drugs Market
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
142
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
20. (c) AZOTH Analytics
About Azoth Analytics Pvt Ltd.
Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy
Application. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food &
beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic
market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).
Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for
any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not warranty the completeness of the information and data. Also, analysis
provided in the report are meant for customers’ internal use only and not for general publication or disclosure to third parties.
22